๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Screening for hepatocellular carcinoma

โœ Scribed by Jane Collier; Morris Sherman

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
70 KB
Volume
27
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Screening for hepatocellular carcinoma:
Screening for hepatocellular carcinoma: From lack of evidence to common sense
โœ Alain Braillon ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 411 KB

We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no

Percutaneous ablation for hepatocellular
Percutaneous ablation for hepatocellular carcinoma
โœ George N. Ioannou ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 149 KB

We read with interest the paper by Di Martino et al. published in the December 2004 issue of HEPATOLOGY 1 that examines estrogen-related effects on hepatitis C fibrosis. Specifically, progression of hepatitis C fibrosis was correlated with prior pregnancies, menopausal status, past use of oral contr

Adjuvant interferon for hepatocellular c
Adjuvant interferon for hepatocellular carcinoma
โœ Shuichi Okada; Toshiya Sato; Seiichiro Yamamoto ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 76 KB

We read with interest the recent article by Ikeda et al. 1 and the accompanying editorial 2 on the use of interferon beta (IFN-โค) to prevent recurrent hepatocellular carcinoma (HCC) after treatment of the primary tumor. We offer comments from an oncologic perspective. The investigators repeatedly n